Showing results (831-840 of 2,410) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|August 14, 2018
Infusion administration billing for vedolizumab and infliximab in inflammatory bowel diseaseKyle Null, Varun Kumar, Trevor Lissoos, et al.Journal of Medical Economics|June 1, 2017
Cost reduction from resolution/improvement of carcinoid syndrome symptoms following treatment with above-standard dose of octreotide LARLynn Huynh, Todor Totev, Francis Vekeman, et al.Journal of Medical Economics|June 1, 2017
Burden of illness associated with sinusoidal obstruction syndrome/veno-occlusive disease in patients with hematopoietic stem cell transplantationZhun Cao, Kathleen F Villa, Craig B Lipkin, et al.Journal of Medical Economics|May 24, 2017
Current and projected patient and insurer costs for the care of patients with non-small cell lung cancer in the United States through 2040Lisa M Hess, Zhanglin Lin Cui, Yixun Wu, et al.Journal of Medical Economics|May 24, 2017
Cost-effectiveness of omalizumab add-on to standard-of-care therapy in patients with uncontrolled severe allergic asthma in a Brazilian healthcare settingCibele Suzuki, Nilceia Lopes da Silva, Praveen Kumar, et al.Journal of Medical Economics|April 28, 2018
Heart rate variability testing: could it change spending for rheumatoid arthritis patients in the United States? An exploratory economic analysisMarita Zimmermann, Elisabeth Vodicka, Andrew J Holman, et al.Journal of Medical Economics|April 24, 2018
Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United StatesEllis J Neufeld, Robert F Sidonio, Ken O'Day, et al.Journal of Medical Economics|May 10, 2018
Healthcare resource utilization with ixazomib or placebo plus lenalidomide-dexamethasone in the randomized, double-blind, phase 3 TOURMALINE-MM1 study in relapsed/refractory multiple myelomaParameswaran Hari, Huamao Mark Lin, Yanyan Zhu, et al.Journal of Medical Economics|July 6, 2018
Where can obesity management policy make the largest impact? Evaluating sub-populations through a microsimulation approachWenqing Su, Fang Chen, Timothy M Dall, et al.Journal of Medical Economics|July 12, 2018
Systemic lupus erythematosus and associated healthcare resource consumption in selected cities from the Russian Federation, Republic of Kazakhstan and Ukraine: the ESSENCE studyE Nasonov, S Soloviev, J E Davidson, et al.Pageof 241